Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Dose Escalation Using Gold Markers in Image Guided Volumetric Modulated Arc Radiotherapy to the Focal Lesion Micro Boost of Localized Prostate Cancer

NCT03384199 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.

NCT NCT03384199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03384199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Dose Escalation Using Gold Markers in Image Guided Volumetric Modulated Arc Radiotherapy to the Focal Lesion Micro Boost of Localized Prostate Cancer
Lead sponsor
Kasr El Aini Hospital
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2016
Completion date
April 30, 2018
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic adenocarcinoma